ArticlePloS one2012

Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model.

Daniel Wicklein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.